Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemotherapy With or Without Enoxaparin in Pancreatic Cancer (PROSPECT)
This study has been completed.
Study NCT00785421   Information provided by CONKO-Studiengruppe

First Received on November 4, 2008.   Last Updated on June 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pancreatic Cancer
Additional conditions recognized in this trial
Pancreatic Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Site
Pancreatic Diseases
Interventions listed in this trial
enoxaparin
chemotherapy with LMWH - enoxaparin
only chemotherapy
Additional drug interventions recognized in this trial
Cisplatin
Folic Acid
Gemcitabine
Heparin, Low-Molecular-Weight
Leucovorin
Levoleucovorin
More general drug interventions related to this trial
Anti-Infective Agents
Anticoagulants
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Cardiovascular Agents
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Growth Substances
Hematinics
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
CONKO-Studiengruppe
Sanofi
Amgen
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services